Pierre Legault Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Pierre Legault.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Pierre Legault. Pierre Legault is Director in NPS PHARMACEUTICALS INC ($NPSP) and Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Tobira Therapeutics, Inc. ($TBRA) and Chief Executive Officer in NephroGenex, Inc. ($NRX) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in Urovant Sciences Ltd. ($UROV) and Director in BICYCLE THERAPEUTICS plc ($BCYC).

Latest Insider Trading Transactions of Pierre Legault

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARMO, BCYC, CYCC, NRX, NPSP, SNDX, TBRA, UROV

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 09 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	M	8.74	24,838	217,084	173,312
Apr 09 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	32.13	239	7,679	0	239 to 0 (-100.00 %)
Apr 09 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	31.40	12,099	379,909	239	12.3 K to 239 (-98.06 %)
Apr 09 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	32.00	12,500	400,000	12,338	24.8 K to 12.3 K (-50.33 %)
Apr 09 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Buy	M	8.74	24,838	217,084	24,838	0 to 24.8 K
Apr 07 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	M	8.83	162	1,430	198,150
Apr 07 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	31.07	162	5,033	0	162 to 0 (-100.00 %)
Apr 07 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Buy	M	8.83	162	1,430	162	0 to 162
Apr 02 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	M	8.78	10,000	87,800	198,312
Apr 02 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	30.00	10,000	300,000	0	10 K to 0 (-100.00 %)
Apr 02 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	M	8.78	10,000	87,800	198,312
Apr 02 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Buy	M	8.78	10,000	87,800	10,000	0 to 10 K
Apr 02 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	30.00	10,000	300,000	0	10 K to 0 (-100.00 %)
Apr 02 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Buy	M	8.78	10,000	87,800	10,000	0 to 10 K
Mar 19 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	M	8.85	7,784	68,888	208,312
Mar 19 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	29.00	7,784	225,736	0	7.8 K to 0 (-100.00 %)
Mar 19 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Buy	M	8.85	7,784	68,888	7,784	0 to 7.8 K
Mar 16 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	M	8.86	2,216	19,634	216,096
Mar 16 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Sell	S	29.00	2,216	64,264	0	2.2 K to 0 (-100.00 %)
Mar 16 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Buy	M	8.86	2,216	19,634	2,216	0 to 2.2 K
Feb 05 2021	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Grant	A	0.00	16,000	0	16,000	0 to 16 K
Jan 05 2021	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	A	17.95	38,000	682,100	38,000
Jul 23 2020	UROV	Urovant Sciences L ...	Legault Pierre	Director	Option Exercise	A	9.38	15,000	140,700	15,000
Jul 23 2020	UROV	Urovant Sciences L ...	Legault Pierre	Director	Grant	A	0.00	9,000	0	21,480	12.5 K to 21.5 K (+72.12 %)
Jan 14 2020	UROV	Urovant Sciences L ...	Legault Pierre	Director	Grant	A	0.00	12,480	0	12,480	0 to 12.5 K
Jan 06 2020	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	A	9.82	32,000	314,240	32,000
Jul 11 2019	UROV	Urovant Sciences L ...	Legault Pierre	Director	Option Exercise	A	8.78	25,000	219,500	25,000
Jun 12 2019	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Option Exercise	A	7.88	24,000	189,120	24,000
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	A	14.00	116,827	1,635,578	116,827
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Legault Pierre	Director	Option Exercise	A	14.00	116,827	1,635,578	116,827
Nov 26 2018	UROV	Urovant Sciences L ...	Legault Pierre	Director	Option Exercise	A	8.01	36,650	293,567	36,650
Nov 26 2018	UROV	Urovant Sciences L ...	Legault Pierre	Director	Option Exercise	A	8.01	36,650	293,567	36,650
Jun 22 2018	ARMO	ARMO BioSciences, ...	Legault Pierre	Director	Option Exercise	D	6.73	55,765	375,538	0
Jun 22 2018	ARMO	ARMO BioSciences, ...	Legault Pierre	Director	Option Exercise	D	39.97	18,000	719,460	0
May 25 2018	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Option Exercise	A	8.93	14,000	125,020	14,000
Mar 28 2018	ARMO	ARMO BioSciences, ...	Legault Pierre	Director	Option Exercise	A	39.97	18,000	719,460	18,000
Feb 12 2018	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Option Exercise	A	9.63	10,000	96,300	10,000
May 19 2017	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Option Exercise	A	13.58	5,000	67,900	5,000
May 19 2017	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Option Exercise	A	13.58	10,000	135,800	10,000
Jan 05 2017	SNDX	Syndax Pharmaceuti ...	Legault Pierre		Option Exercise	A	7.08	20,000	141,600	20,000
Nov 03 2016	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	D	8.19	17,695	144,922	0
Nov 03 2016	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	D	7.91	17,778	140,624	0
Nov 03 2016	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	D	16.52	15,500	256,060	0
Nov 03 2016	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	D	42.93	535	22,968	0
Nov 03 2016	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	D	43.83	6,111	267,845	0
Jan 14 2016	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	A	7.91	17,778	140,624	17,778
Nov 12 2015	NRX	NephroGenex, Inc.	Legault Pierre	Chief Executive Off ...	Grant	A	0.00	646,930	0	659,430	12.5 K to 659.4 K (+5,175.44 %)
Jul 13 2015	TBRA	Tobira Therapeutic ...	Legault Pierre	Director	Option Exercise	A	16.52	15,500	256,060	15,500
May 04 2015	NRX	NephroGenex, Inc.	Legault Pierre	Chief Executive Off ...	Option Exercise	A	7.31	50,000	365,500	50,000
Feb 24 2015	NPSP	NPS PHARMACEUTICAL ...	Legault Pierre	Director	Option Exercise	D	0.00	3,816	0	0
Feb 24 2015	NPSP	NPS PHARMACEUTICAL ...	Legault Pierre	Director	Option Exercise	D	27.29	20,257	552,814	0
Feb 21 2008	CYCC	Cyclacel Pharmaceu ...	Legault Pierre	Director	Option Exercise	A	4.31	35,000	150,850	35,000
Mar 13 2007	CYCC	Cyclacel Pharmaceu ...	Legault Pierre	Director	Option Exercise	A	7.80	35,000	273,000	35,000

Page: 1